Alliancebernstein L.P. Evelo Biosciences, Inc. Transaction History

Alliancebernstein L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.46 - $3.55 $15,184 - $36,920	-10,400 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.66 - $6.63 $9,310 - $23,205	-3,500 Reduced 25.18%	10,400 $35,000
Q2 2021 Jul 30, 2021	BUY	$9.43 - $16.6 $26,404 - $46,480	2,800 Added 25.23%	13,900 $191,000
Q1 2021 May 06, 2021	SELL	$9.71 - $18.6 $16,507 - $31,620	-1,700 Reduced 13.28%	11,100 $119,000
Q3 2020 Nov 12, 2020	SELL	$3.81 - $5.73 $8,382 - $12,606	-2,200 Reduced 14.67%	12,800 $67,000
Q2 2020 Aug 13, 2020	BUY	$3.53 - $6.12 $13,767 - $23,868	3,900 Added 35.14%	15,000 $74,000
Q1 2020 May 14, 2020	BUY	$3.21 - $7.06 $2,568 - $5,648	800 Added 7.77%	11,100 $42,000
Q2 2019 Aug 14, 2019	BUY	$6.52 - $9.42 $1,304 - $1,884	200 Added 1.98%	10,300 $92,000
Q1 2019 May 14, 2019	BUY	$7.5 - $15.31 $75,750 - $154,631	10,100 New	10,100 $81,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.